Veronique M. De Mas

Toulouse, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

Targeted Next-Generation Sequencing of JAK2, CALR, and MPL in 10 326 Patients With Suspected Myeloproliferative Neoplasm.

Targeted Next-Generation Sequencing of JAK2, CALR, and MPL in 10 326 Patients With Suspected Myeloproliferative Neoplasm.

Journal: American journal of hematology
Published: April 29, 2026

Limited Prognostic Value of ELN Classification and Relevance of Molecular Ontogeny in Acute Myeloid Leukemia post Myeloproliferative Neoplasms: A Retrospective Multicenter Study.

Limited Prognostic Value of ELN Classification and Relevance of Molecular Ontogeny in Acute Myeloid Leukemia post Myeloproliferative Neoplasms: A Retrospective Multicenter Study.

Journal: Acta haematologica
Published: February 27, 2026

Prediction of bone marrow fibrosis from complete blood count in myeloproliferative neoplasms (FIBOM-AI): a multicentre machine learning model development and validation study.

Prediction of bone marrow fibrosis from complete blood count in myeloproliferative neoplasms (FIBOM-AI): a multicentre machine learning model development and validation study.

Journal: The Lancet. Haematology
Published: January 30, 2026

Targeting systemic and tumor metabolic balances with ketogenic diets enhance efficacy of therapy in FLT3-ITD acute myeloid leukemia.

Targeting systemic and tumor metabolic balances with ketogenic diets enhance efficacy of therapy in FLT3-ITD acute myeloid leukemia.

Journal: Cell reports
Published: April 18, 2025

A molecular signature predicts hematologic evolution in polycythemia vera patients.

A molecular signature predicts hematologic evolution in polycythemia vera patients.

Journal: Leukemia
Published: April 03, 2025

A metabolism-specific drug-repurposing screen reveals itraconazole as a potent OXPHOS inhibitor in acute myeloid leukemia.

A metabolism-specific drug-repurposing screen reveals itraconazole as a potent OXPHOS inhibitor in acute myeloid leukemia.

Journal: Blood
Published: December 03, 2024

Could Old-School Erythroleukaemia be Back in Style Thanks to TP53?

Could Old-School Erythroleukaemia be Back in Style Thanks to TP53?

Journal: EJHaem
Published: December 03, 2024

HLA evolutionary divergence score after donor lymphocyte infusion following allogeneic hematopoietic stem cell transplantation.

HLA evolutionary divergence score after donor lymphocyte infusion following allogeneic hematopoietic stem cell transplantation.

Journal: HemaSphere
Published: July 29, 2024

Detection of SARS-CoV-2 in bone marrow megakaryocytes and elevated emperipolesis in COVID-19 patients with thrombocytopenia.

Detection of SARS-CoV-2 in bone marrow megakaryocytes and elevated emperipolesis in COVID-19 patients with thrombocytopenia.

Journal: Journal of thrombosis and haemostasis : JTH
Published: June 13, 2024

When acute promyelocytic leukaemia changes its face in the peripheral blood.

When acute promyelocytic leukaemia changes its face in the peripheral blood.

Journal: EJHaem
Published: February 08, 2024

CALR-mutated patients with low allele burden represent a specific subtype of essential thrombocythemia: A study on behalf of FIM and GBMHM.

CALR-mutated patients with low allele burden represent a specific subtype of essential thrombocythemia: A study on behalf of FIM and GBMHM.

Journal: American journal of hematology
Published: November 10, 2023

Erythroblastic islands: A fertile ground for CD47 expression in myelodysplastic syndrome and acute erythroid leukaemia.

Erythroblastic islands: A fertile ground for CD47 expression in myelodysplastic syndrome and acute erythroid leukaemia.

Journal: EJHaem
Published: October 31, 2023
Showing 1-12 of 20

Last Updated: 09/26/2026